OnRAMP for Regulating AI in Medical Products

  title={OnRAMP for Regulating AI in Medical Products},
  author={David C. Higgins},
Title OnRAMP for Regulating AI in Medical Products Author(s), and Corresponding Author(s)* David C. Higgins* Dr. David C. Higgins Berlin Institute of Health, Anna-Louisa-Karsch-Straße 2, 10178 Berlin E-mail: dave@uiginn.com 

Tables from this paper


Mathematical and Statistical Skills in the Biopharmaceutical Industry
After glancing at the book title, we initially thought the focus would be on mathematical formulas and statistical methodologies that are often used in clinical trials. To our pleasant surprise, th...
Artificial intelligence, bias and clinical safety
This analysis is written with the dual aim of helping clinical safety professionals to critically appraise current medical AI research from a quality and safety perspective, and supporting research and development in AI by highlighting some of the clinical safety questions that must be considered if medical application of these exciting technologies is to be successful.
MINIMAR (MINimum Information for Medical AI Reporting): Developing reporting standards for artificial intelligence in health care
MINIMAR (MINimum Information for Medical AI Reporting), a proposal describing the minimum information necessary to understand intended predictions, target populations, and hidden biases, and the ability to generalize these emerging technologies is presented.
The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database
The first comprehensive and open access database of strictly AI/ML-based medical technologies that have been approved by the FDA is launched, which aims to raise awareness of the importance of regulatory bodies, clearly stating whether a medical device isAI/ML based or not.
Evaluation of colorectal cancer subtypes and cell lines using deep learning
A deep learning based method is developed to measure the similarity between CRC tumors and other tumors or disease models such as cancer cell lines and proposes a refined colorectal cancer sample classification and provides best-matching cell lines in terms of multi-omics for the different subtypes.
Reporting of artificial intelligence prediction models
The theory that dictators might themselves be a cause of poverty and illness is supported, and that democrats, however befuddled and disorganised, better serve their people is supported.
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension
The SPIRIT-AI extension is a new reporting guideline for clinical trials protocols evaluating interventions with an AI component and its use will assist editors and peer-reviewers, as well as the general readership, to understand, interpret and critically appraise the design and risk of bias for a planned clinical trial.
Calculating the sample size required for developing a clinical prediction model
In this article, the authors provide guidance on how to calculate the sample size required to develop a clinical prediction model.
Model Cards for Model Reporting
This work proposes model cards, a framework that can be used to document any trained machine learning model in the application fields of computer vision and natural language processing, and provides cards for two supervised models: One trained to detect smiling faces in images, and one training to detect toxic comments in text.
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension
The CONSORT-AI extension is a new reporting guideline for clinical trials evaluating interventions with an AI component that recommends that investigators provide clear descriptions of the AI intervention, including instructions and skills required for use, the setting in which theAI intervention is integrated and providing analysis of error cases.